Loading…

Human Regulatory CD8+ T Cells

Administration of a humanized monoclonal anti‐CD3 antibody (mAb) to patients with type 1 diabetes (T1D) increases their C‐peptide responses and the CD8/CD4 ratio. Incubation of human peripheral blood mononuclear cells (PBMC) with mAb in vitro has been shown to induce CD8+ regulatory T cells (Tregs)...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the New York Academy of Sciences 2008-12, Vol.1150 (1), p.234-238
Main Authors: Ablamunits, Vitaly, Bisikirska, Brygida C., Herold, Kevan C.
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Administration of a humanized monoclonal anti‐CD3 antibody (mAb) to patients with type 1 diabetes (T1D) increases their C‐peptide responses and the CD8/CD4 ratio. Incubation of human peripheral blood mononuclear cells (PBMC) with mAb in vitro has been shown to induce CD8+ regulatory T cells (Tregs) capable of inhibiting proliferation of CD4+ T cells. We hypothesized that CD8+ Tregs function through secretion of cytokines. To test that possibility, we generated CD8+ Tregs, sorted them by FACS, incubated them with syngeneic CD8‐depleted PBMC in the presence of staphylococcal enterotoxin B (SEB), and measured proliferation of T cells and cytokines. Using neutralizing anti‐cytokine mAbs, we show that the inhibitory effect of CD8+ Tregs could be partially alleviated by anti‐CCL‐4, anti‐TNF, and to a lesser extent anti‐IL2, suggesting that these cytokines contribute to CD8+ Treg function.
ISSN:0077-8923
1749-6632
1930-6547
DOI:10.1196/annals.1447.000